Aclaris Therapeutics ACRS
NASDAQ ACRS
$4.39 -0.02 (-0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aclaris Therapeutics (ACRS) Return on Assets [ROA] (2015 - 2026)

Updated

Aclaris Therapeutics (ACRS) reported Return on Assets [ROA] of -42.06% for Q2 2026, up 29.40 percentage points from -71.46% a year earlier but down 1.14 percentage points from the prior quarter.

Analysis

Aclaris Therapeutics (ACRS) Return on Assets [ROA] (2015 - 2026) Analysis & Trends

For FY2025, Aclaris Therapeutics posted Return on Assets [ROA] of -36.10%, up 27.13 percentage points from FY2024.

  • Return on Assets [ROA] has a five-year change of +24.24 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -63.23% in FY2024 (-24.08 pp), -39.15% in FY2023 (-4.79 pp), -34.36% in FY2022 (+22.07 pp) and -56.44% in FY2021 (+3.91 pp).
  • Five-year quarterly Return on Assets [ROA] spans a low of -79.64% in Q3 2025 and a high of -22.28% in Q3 2024.
  • Year over year, Return on Assets [ROA] has now increased in each of the last three quarters, with an average year-over-year change of -3.47 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q3 2021 (a gain of 42.48 percentage points); the low point was Q3 2025 (a drop of 57.35 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -40.93% (Q1 2026), -40.92% (Q4 2025) and -79.64% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Aclaris Therapeutics 613.83 Mn 613.83 Mn 1.41 Mn -42.06%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -42.06%
Mar 31, 2026 -40.93%
Dec 31, 2025 -40.92%
Sep 30, 2025 -79.64%
Jun 30, 2025 -71.46%
Mar 31, 2025 -63.55%
Dec 31, 2024 -66.54%
Sep 30, 2024 -22.28%
Jun 30, 2024 -35.24%
Mar 31, 2024 -43.00%
Dec 31, 2023 -44.67%
Sep 30, 2023 -52.90%
Jun 30, 2023 -48.00%
Mar 31, 2023 -41.65%
Dec 31, 2022 -34.41%
Sep 30, 2022 -30.64%
Jun 30, 2022 -33.24%
Mar 31, 2022 -33.92%
Dec 31, 2021 -35.31%
Sep 30, 2021 -29.46%
API Access

Aclaris Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ACRS&period=max&api_key=YOUR_API_KEY